These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 26492923)

  • 1. Long-term CD4 lymphopenia is associated with accelerated decline of kidney allograft function.
    Luque Y; Jamme M; Rabant M; DeWolf S; Noël LH; Thervet E; Chatenoud L; Snanoudj R; Anglicheau D; Legendre C; Candon S; Zuber J
    Nephrol Dial Transplant; 2016 Mar; 31(3):487-95. PubMed ID: 26492923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term kinetics of a T-lymphocytes subset in kidney transplant recipients: relationship with posttransplant malignancies.
    Glowacki F; Al Morabiti M; Lionet A; Labalette M; Provot F; Noel C; Hazzan M
    Transplant Proc; 2009 Oct; 41(8):3323-5. PubMed ID: 19857742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pretransplant CD4 Count Influences Immune Reconstitution and Risk of Infectious Complications in Human Immunodeficiency Virus-Infected Kidney Allograft Recipients.
    Suarez JF; Rosa R; Lorio MA; Morris MI; Abbo LM; Simkins J; Guerra G; Roth D; Kupin WL; Mattiazzi A; Ciancio G; Chen LJ; Burke GW; Goldstein MJ; Ruiz P; Camargo JF
    Am J Transplant; 2016 Aug; 16(8):2463-72. PubMed ID: 26953224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired thymic function and CD4+ T lymphopenia, but not mannose-binding lectin deficiency, are risk factors for Pneumocystis jirovecii pneumonia in kidney transplant recipients.
    Schürmann M; Schürmann D; Schindler R; Meisel C; Liman P; Kruse J; Enghard P; König J; Schmidt D; Reinke P; Nickel P
    Transpl Immunol; 2013 Jun; 28(4):159-63. PubMed ID: 23684946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of urinary CD4⁺ and CD8⁺ T cells in kidney transplantation patients with polyomavirus BK infection and allograft rejection.
    van Doesum WB; Abdulahad WH; van Dijk MC; Dolff S; van Son WJ; Stegeman CA; Sanders JS
    Transpl Infect Dis; 2014 Oct; 16(5):733-43. PubMed ID: 25092256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for impaired CD4+ T-cell reconstitution following rabbit antithymocyte globulin treatment in kidney transplantation.
    Longuet H; Sautenet B; Gatault P; Thibault G; Barbet C; Marliere JF; Halimi JM; Lebranchu Y; Baron C; Büchler M
    Transpl Int; 2014 Mar; 27(3):271-9. PubMed ID: 24279588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ATG induction in renal transplant recipients: Long-term hazard of severe infection is associated with long-term functional T cell impairment but not the ATG-induced CD4 cell decline.
    Weimer R; Ettrich M; Renner F; Dietrich H; Süsal C; Deisz S; Padberg W; Opelz G
    Hum Immunol; 2014 Jun; 75(6):561-9. PubMed ID: 24530759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune function assay (ImmuKnow) as a predictor of allograft rejection and infection in kidney transplantation.
    He J; Li Y; Zhang H; Wei X; Zheng H; Xu C; Bao X; Yuan X; Hou J
    Clin Transplant; 2013; 27(4):E351-8. PubMed ID: 23682828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of CD4
    McRae JL; Chia JS; Pommey SA; Dwyer KM
    Nephrology (Carlton); 2017 Jul; 22(7):505-512. PubMed ID: 27517975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphocyte subsets in renal transplant recipients with de novo genitourinary malignancies.
    Guichard G; Rebibou JM; Ducloux D; Simula-Faivre D; Tiberghien P; Chalopin JM; Bittard H; Saas P; Kleinclauss F
    Urol Int; 2008; 80(3):257-63. PubMed ID: 18480627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune cell function assay does not identify biopsy-proven pediatric renal allograft rejection or infection.
    Ryan CM; Chaudhuri A; Concepcion W; Grimm PC
    Pediatr Transplant; 2014 Aug; 18(5):446-52. PubMed ID: 24930482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preformed donor-specific antibodies and risk of antibody-mediated rejection in repeat renal transplantation.
    Tsapepas DS; Vasilescu R; Tanriover B; Coppleson Y; Rekhtman Y; Hardy MA; Dube G; Crew RJ; Ratner LE; Cohen DJ; Mohan S
    Transplantation; 2014 Mar; 97(6):642-7. PubMed ID: 24637863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accelerated podocyte detachment early after kidney transplantation is related to long-term allograft loss of function.
    Naik AS; Afshinnia F; Aqeel J; Cibrik DM; Samaniego M; Wickman L; Wang SQ; Chowdhury M; Wiggins RC
    Nephrol Dial Transplant; 2019 Jul; 34(7):1232-1239. PubMed ID: 30500951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term renal transplant function in recipient of simultaneous kidney and pancreas transplant maintained with two prednisone-free maintenance immunosuppressive combinations: tacrolimus/mycophenolate mofetil versus tacrolimus/sirolimus.
    Gallon LG; Winoto J; Chhabra D; Parker MA; Leventhal JR; Kaufman DB
    Transplantation; 2007 May; 83(10):1324-9. PubMed ID: 17519781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pre-existing diabetes is a risk factor for increased rates of cellular rejection after kidney transplantation: an observational cohort study.
    Johal S; Jackson-Spence F; Gillott H; Tahir S; Mytton J; Evison F; Stephenson B; Nath J; Sharif A
    Diabet Med; 2017 Aug; 34(8):1067-1073. PubMed ID: 28510327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sepsis after renal transplantation: Clinical, immunological, and microbiological risk factors.
    Schachtner T; Stein M; Reinke P
    Transpl Infect Dis; 2017 Jun; 19(3):. PubMed ID: 28296035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors of long-term graft loss in renal transplant recipients with chronic allograft dysfunction.
    Khalkhali HR; Ghafari A; Hajizadeh E; Kazemnejad A
    Exp Clin Transplant; 2010 Dec; 8(4):277-82. PubMed ID: 21143092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stabilization of renal function after the first year of follow-up in kidney transplant recipients treated for significant BK polyomavirus infection or BK polyomavirus-associated nephropathy.
    Simard-Meilleur MC; Bodson-Clermont P; St-Louis G; Pâquet MR; Girardin C; Fortin MC; Cardinal H; Hébert MJ; Lévesque R; Renoult E
    Transpl Infect Dis; 2017 Jun; 19(3):. PubMed ID: 28207975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An investigation to assess the potential of CD25highCD4+ T cells to regulate responses to donor alloantigens in clinically stable renal transplant recipients.
    Akl A; Jones ND; Rogers N; Bakr MA; Mostafa A; El Shehawy el M; Ghoneim MA; Wood KJ
    Transpl Int; 2008 Jan; 21(1):65-73. PubMed ID: 17887959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD4
    Freiwald T; Büttner S; Cheru NT; Avaniadi D; Martin SS; Stephan C; Pliquett RU; Asbe-Vollkopf A; Schüttfort G; Jacobi V; Herrmann E; Geiger H; Hauser IA
    Clin Transplant; 2020 Sep; 34(9):e13877. PubMed ID: 32277846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.